2008
DOI: 10.1080/17482940801910942
|View full text |Cite
|
Sign up to set email alerts
|

First use of a novel plug-and-play percutaneous circulatory assist device for high-risk coronary angioplasty

Abstract: This case illustrates the safe and easy use of a novel plug-and-play percutaneous circulatory assist device for high risk interventions. It may be recommended for use in emergency situations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0
1

Year Published

2008
2008
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 19 publications
0
4
0
1
Order By: Relevance
“…New devices on the horizon include the LIFEBRIDGE system (Medizintechnik GmbH, Ampfing, Germany), which is a portable, modular, rapidly available mechanical circulatory support that could be used for short-term peripheral CPB for acute cardiopulmonary failure or as a bridge to procedure for highrisk PCI (Fig 3). [41][42][43] The system has achieved CE certification, and the clinical introduction of the system has started in Europe. 43 Although the LIFEBRIDGE is not approved by the Food and Drug Administration, there are numerous theoretic and practical advantages over all other systems discussed previously.…”
Section: Future Applications and Devicesmentioning
confidence: 99%
See 1 more Smart Citation
“…New devices on the horizon include the LIFEBRIDGE system (Medizintechnik GmbH, Ampfing, Germany), which is a portable, modular, rapidly available mechanical circulatory support that could be used for short-term peripheral CPB for acute cardiopulmonary failure or as a bridge to procedure for highrisk PCI (Fig 3). [41][42][43] The system has achieved CE certification, and the clinical introduction of the system has started in Europe. 43 Although the LIFEBRIDGE is not approved by the Food and Drug Administration, there are numerous theoretic and practical advantages over all other systems discussed previously.…”
Section: Future Applications and Devicesmentioning
confidence: 99%
“…[41][42][43] The system has achieved CE certification, and the clinical introduction of the system has started in Europe. 43 Although the LIFEBRIDGE is not approved by the Food and Drug Administration, there are numerous theoretic and practical advantages over all other systems discussed previously. It is simple to use, safe, and practically a "plug-andplay" device.…”
Section: Future Applications and Devicesmentioning
confidence: 99%
“…Die Kanülen in A. und V. femoralis haben dabei Außendurchmesser zwischen 15F und 21F, worüber Flussraten von 3,2-5,6 l/min zu erzielen sind. Solche Notfallsysteme kön-nen auch im kompletten Kreislaufstillstand implantiert werden, wodurch temporär eine vollständige Übernahme von Herz-und Lungenfunktion möglich ist und der Patient einer weitergehenden Diagnostik und Therapie zugeführt werden kann [9]. …”
Section: Frühest Mögliche Koronare Reperfusionunclassified
“…Recently, a compact CPS system designed for simplified application [4][5][6] has been introduced with a menu-guided set-up and priming procedure. This systematic system is particularly suited for emergency CPS where quick device readiness and safety are of prime importance.…”
Section: Introductionmentioning
confidence: 99%